Overview
Pei-ching Chang practices practicing medicine in Taipei, Taiwan.
Their clinical expertise encompasses Prostate Cancer, Chronic Kidney Disease, Hyperparathyroidism, and End-Stage Renal Disease (ESRD).
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pei-ching Chang
Is Pei-ching Chang a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Pei-ching Chang is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pei-ching Chang participate in research or clinical trials?
Yes. Pei-ching Chang has published 13 articles and abstracts on conditions like Prostate Cancer. You can view a list of Pei-ching Chang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Kidney DiseaseChang isExperienced. Learn about Chronic Kidney Disease.
- End-Stage Renal Disease (ESRD)
- HyperparathyroidismChang isExperienced. Learn about Hyperparathyroidism.
- Prostate CancerChang isExperienced. Learn about Prostate Cancer.